세계의 군유전체학 시장 : 시장 분석과 예측(용도별, 기술별, 제품별, 사용자별) - 주요 컨설턴트 가이드 첨부(2025-2029년)

Metagenomic Markets. Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2025 to 2029

US $ 6,995 ￦ 9,700,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,554,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,408,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

건강과 질병에 있어서의 유전학의 역할은 지금 바로 이해되고 있습니다. 물질을 조사했습니다. 그 과정에서 감염증, 암, 항균제 내성, 환자의 유전체에 대해 알 수 있다는 완전히 새로운 접근입니다.

본 보고서는 세계의 군유전체학 시장에 대해 조사했으며, 시장 개요와 함께 용도별, 기술별, 제품별, 사용자별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 시장 가이드

제2장 소개와 시장 정의

• 군유전체학이란 무엇인가
• 시장의 정의
• 조사 방법
• 관점: 헬스케어와 IVD 업계
• 염색체, 유전자, 후성 유전학

제3장 시장 개요

• 시장 진입기관
  • 학술연구기관
  • 진단 시험 개발자
  • 계장 공급자
  • 약품 및 시약 제조업체
  • 병리 공급자
  • 독립계 임상 실험실
  • 공공의 국립/지역 연구소
  • 병원 검사실
  • 임상 실험실
  • 감사기관
  • 인증기관
• 군유전체학 용도
• 임상산업 구조

제4장 시장 동향

• 성장 촉진요인
• 성장 억제요인
• 계측, 자동화, 진단의 동향

제5장 군유전체학의 최근 동향

제6장 주요 기업 프로파일

• Arc Bio
• BaseClear
• BGI Genomics Co. Ltd
• Biome Makers
• bioMerieux Diagnostics
• Bio-Rad Laboratories, Inc
• CosmosID
• Element Biosciences
• Fusion Genomics.
• Helix OpCo
• Illumina
• Institute for Metagenomics
• Karius
• Metabiomics Corp
• Metagenomi
• MetaSUB International Consortium
• Microbiome Insights
• MicroGenDx
• Molecular Stethoscope
• Norgen Biotek Corp.
• Noscendo
• Novogene Bioinformatics Technology Co., Ltd.
• One Codex
• OraSure Technologies
• Oxford Nanopore Technologies
• Pacific Biosciences
• PathoQuest SA
• Perkin Elmer
• Promega
• Qiagen
• Second Genome
• Siemens Healthineers
• Sysmex
• Takara Bio
• Ultima Genomics
• Zymo Research Corp

제7장 세계 시장 규모

• 세계 시장, 국가별
• 세계 시장, 용도별
• 세계 시장, 기술별
• 세계 시장, 제품별
• 세계 시장, 사용자별

제8장 용도별 시장 규모

• 임상
• 마이크로바이옴
• 농업
• 산업 및 기타

제9장 기술별 시장 규모

• 16srRNA
• Shotgun
• WGS
• 기타

제10장 제품별 시장 규모

• 기기
• 시약 및 키트
• 소프트웨어
• 서비스

제11장 유저별 시장 규모

• 학술
• 임상
• 제약
• 기타

제12장 부록

JHS

영문 목차

영문목차

Report Overview:

Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. Metagenomic Testing looks at all the genetic material in a sample. In the process it learns about infection, cancer, antimicrobial resistance, and the patient genome. It's a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers. In everything from human medical treatment to wastewater studies this new approach is creating startling answers. And finding new kinds of organisms and pathogens in the process. Already some minor medical miracles have been accomplished. This report looks at the technology, the applications, the users and the types of products that will be sold. The report includes detailed breakouts for 14 countries and 5 regions.

Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guide for Executives and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. What is Metagenomics?
• 2.2. Market Definition
  • 2.2.1. Revenue Market Size.
  • 2.2.2. Clinical
  • 2.2.3. Microbiome
  • 2.2.4. Agricultural
  • 2.2.5. Environmental & Other
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics
• 2.5. Chromosomes, Genes and Epigenetics
  • 2.5.1. Chromosomes
  • 2.5.2. Genes
  • 2.5.3. Epigenetics

3. Market Overview

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. Metagenomics Applications
  • 3.2.1. Clinical Metagenomics
  • 3.2.2. Diagnostic Use
  • 3.2.3. Syndromic Multiplex vs. Metagenomic Testing
  • 3.2.4. Antimicrobial Resistance
  • 3.2.5. Managing the Microbiome
  • 3.2.6. Public Health Use
• 3.3. Clinical Industry Structure
  • 3.3.1. Hospital's Testing Share
  • 3.3.2. Economies of Scale
  • 3.3.3. Hospital vs. Central Lab
  • 3.3.4. Physician Office Lab's
  • 3.3.5. Physician's and POCT

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. A New Approach to Diagnostics
  • 4.1.2. The Aging Effect
  • 4.1.3. The Known and the Unknown
  • 4.1.4. A Research Bonanza
• 4.2. Factors Limiting Growth
  • 4.2.1. Increased Competition Lowers Price
  • 4.2.2. Lower Costs
  • 4.2.3. Testing usage analysis curtailing growth
  • 4.2.4. Wellness has a downside
• 4.3. Instrumentation, Automation and Diagnostic Trends
  • 4.3.1. Traditional Automation and Centralization
  • 4.3.2. The New Automation, Decentralization and Point of Care
  • 4.3.3. Instruments Key to Market Share
  • 4.3.4. Bioinformatics Plays a Role
  • 4.3.5. PCR Takes Command
  • 4.3.6. Next Generation Sequencing Fuels a Revolution
  • 4.3.7. NGS Impact on Pricing
  • 4.3.8. Whole Genome Sequencing, A Brave New World
  • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.3.10. Shifting Role of Diagnostics

5. Metagenomics Recent Developments

• 5.1. Recent Developments
  • 5.1.1. Importance of This Section
  • 5.1.2. How to Use This Section
• 5.2. Delve Bio Showing Delivers Greater Diagnostic Yield
• 5.3. Sewage metagenomics potentially allows surveillance
• 5.4. Rapid metagenomics to reduce AMR and sepsis
• 5.5. UK and U.S. Use Metagenomics for Biothreat Assessment
• 5.6. Phase Genomics Metagenomics Innovation Award
• 5.7. New Method for Human Gut Assessment
• 5.8. Metagenomic sequencing Used for Pneumonia Care
• 5.9. Sepsis Study Shows Metagenomic Clinical Value
• 5.10. Delve Bio to Develop Metagenomic Sequencing Dx
• 5.11. Metagenomics Could be a Game-changer
• 5.12. Model Predicts Millions of Metagenomic Proteins
• 5.13. Microbiome Analysis May Yield False Results
• 5.14. Gut microbiome at center of Parkinson's disease
• 5.15. MicroGenDx, Evvy Partner for Metagenomic Test
• 5.16. Diagnostic accuracy of metagenomic NGS
• 5.17. Metagenomics implicates the gut microbiome
• 5.18. Charities Award $2M for Metagenomic Pathogen Research
• 5.19. Cost-effective metagenomic HiFi sequencing
• 5.20. Microbiome Links Uncovered
• 5.21. Metagenomi Named an Endpoints 11 Winner
• 5.22. Biotia Raises $8M in Series A Financing

6. Profiles of Key Companies

• 6.1. Arc Bio
• 6.2. BaseClear
• 6.3. BGI Genomics Co. Ltd
• 6.4. Biome Makers
• 6.5. bioMerieux Diagnostics
• 6.6. Bio-Rad Laboratories, Inc
• 6.7. CosmosID
• 6.8. Element Biosciences
• 6.9. Fusion Genomics.
• 6.10. Helix OpCo
• 6.11. Illumina
• 6.12. Institute for Metagenomics
• 6.13. Karius
• 6.14. Metabiomics Corp
• 6.15. Metagenomi
• 6.16. MetaSUB International Consortium
• 6.17. Microbiome Insights
• 6.18. MicroGenDx
• 6.19. Molecular Stethoscope
• 6.20. Norgen Biotek Corp.
• 6.21. Noscendo
• 6.22. Novogene Bioinformatics Technology Co., Ltd.
• 6.23. One Codex
• 6.24. OraSure Technologies
• 6.25. Oxford Nanopore Technologies
• 6.26. Pacific Biosciences
• 6.27. PathoQuest S.A.
• 6.28. Perkin Elmer
• 6.29. Promega
• 6.30. Qiagen
• 6.31. Second Genome
• 6.32. Siemens Healthineers
• 6.33. Sysmex
• 6.34. Takara Bio
• 6.35. Ultima Genomics
• 6.36. Zymo Research Corp

7. Global Market Size

• 7.1. Global Market by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Country Market Shares
• 7.2. Global Market by Application
  • 7.2.1. Table - Global Market by Application
  • 7.2.2. Chart - Application Share by Year
  • 7.2.3. Chart - Application Segment Growth Rates
  • 7.2.4. Chart - Application Segment Share Shifts
  • 7.2.5. Chart - Application Segment Share Base Year
  • 7.2.6. Chart - Application Segment Share Final Year
• 7.3. Global Market by Technology
  • 7.3.1. Table - Global Market by Technology
  • 7.3.2. Chart - Technology Share by Year
  • 7.3.3. Chart - Technology Segment Growth Rates
  • 7.3.4. Chart - Technology Segment Share Shifts
  • 7.3.5. Chart - Technology Segment Share Base Year
  • 7.3.6. Chart - Technology Segment Share Final Year
• 7.4. Global Market by Product
  • 7.4.1. Table - Global Market by Product
  • 7.4.2. Chart - Product Share by Year
  • 7.4.3. Chart - Product Segment Growth Rates
  • 7.4.4. Chart - Product Segment Share Shifts
  • 7.4.5. Chart - Product Segment Share Base Year
  • 7.4.6. Chart - Product Segment Share Final Year
• 7.5. Global Market by User
  • 7.5.1. Table - Global Market by User
  • 7.5.2. Chart - User Share by Year
  • 7.5.3. Chart - User Segment Growth Rates
  • 7.5.4. Chart - User Segment Share Shifts
  • 7.5.5. Chart - User Segment Share Base Year
  • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

• 8.1. Clinical Market
  • 8.1.1. Table Clinical - by Country
  • 8.1.2. Chart - Clinical Growth
• 8.2. Microbiome Market
  • 8.2.1. Table Microbiome - by Country
  • 8.2.2. Chart - Microbiome Growth
• 8.3. Agriculture Market
  • 8.3.1. Table Agriculture - by Country
  • 8.3.2. Chart - Agriculture Growth
• 8.4. Industrial & Other Market
  • 8.4.1. Table Industrial & Other - by Country
  • 8.4.2. Chart - Industrial & Other Growth

9. Market Sizes by Technology

• 9.1. 16srRNA Market
  • 9.1.1. Table 16srRNA - by Country
  • 9.1.2. Chart - 16srRNA Growth
• 9.2. Shotgun Market
  • 9.2.1. Table Shotgun - by Country
  • 9.2.2. Chart - Shotgun Growth
• 9.3. WGS Market
  • 9.3.1. Table WGS - by Country
  • 9.3.2. WGS - Growth
• 9.4. Other Technology Market
  • 9.4.1. Table Other Technology - by Country
  • 9.4.2. Chart - Other Technology Growth

10. Market Sizes by Product

• 10.1. Instruments Market
  • 10.1.1. Table Instruments - by Country
  • 10.1.2. Chart - Instrument Growth
• 10.2. Reagents and Kits Market
  • 10.2.1. Table Reagents and Kits - by Country
  • 10.2.2. Chart - Reagents and Kits Growth
• 10.3. Software Market
  • 10.3.1. Table Software - by Country
  • 10.3.2. Software Growth
• 10.4. Services Market
  • 10.4.1. Table Services - by Country
  • 10.4.2. Chart - Services Growth

11. Market Sizes by User

• 11.1. Academic Market
  • 11.1.1. Table Academic - by Country
  • 11.1.2. Chart - Academic Growth
• 11.2. Clinical Market
  • 11.2.1. Table Clinical - by Country
  • 11.2.2. Chart - Clinical Growth
• 11.3. Pharmaceutical Market
  • 11.3.1. Table Pharmaceutical - by Country
  • 11.3.2. Pharmaceutical - Predictive Growth
• 11.4. Other User Market
  • 11.4.1. Table Other User - by Country
  • 11.4.2. Chart - Other User Growth

12. Appendices

• 12.1. United States Medicare System: Laboratory Fees Schedule
• 12.2. The Most Used IVD Assays
• 12.3. The Highest Grossing Assays

관련자료